SSA Swiss Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$796K Sell
3,135
-30
-0.9% -$6.99K 0.3% 63
2026
Q1
$774K Sell
3,165
-105
-3% -$24.5K 0.36% 57
2025
Q4
$677K Sell
3,270
-495
-13% -$97.9K 0.32% 60
2025
Q3
$687K Hold
3,765
0.32% 59
2025
Q2
$634K Sell
3,765
-21,690
-85% -$3.33M 0.31% 59
2025
Q1
$4.23M Buy
+25,455
New +$3.98M 2.17% 9

Other funds holding JNJ

SSA Swiss Advisors's JNJ Position: Q2 2026 in Review

SSA Swiss Advisors reduced its Johnson & Johnson (JNJ) stake by 0.95% in Q2 2026, selling an estimated $6.99K and leaving 3,135 shares worth $796K. The position accounts for 0.3% of the portfolio, ranked #63.

SSA Swiss Advisors first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.23M in Q1 2025. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • SSA Swiss Advisors held 3,135 shares of Johnson & Johnson worth $796K as of Q2 2026.
  • SSA Swiss Advisors sold 30 Johnson & Johnson shares in Q2 2026, an estimated $6.99K.
  • Johnson & Johnson made up 0.3% of SSA Swiss Advisors's portfolio in Q2 2026, its #63 holding.
  • SSA Swiss Advisors first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • SSA Swiss Advisors's Johnson & Johnson position peaked at $4.23M in Q1 2025.
  • 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on SSA Swiss Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.